Stericycle (SRCL)
(Delayed Data from NSDQ)
$46.31 USD
-0.20 (-0.43%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $46.33 +0.02 (0.04%) 7:58 PM ET
2-Buy of 5 2
B Value C Growth B Momentum A VGM
Income Statements
Fiscal Year end for Stericycle, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 2,659 | 2,705 | 2,647 | 2,676 | 3,309 |
Cost Of Goods | 1,645 | 1,679 | 1,630 | 1,622 | 2,134 |
Gross Profit | 1,015 | 1,026 | 1,017 | 1,053 | 1,175 |
Selling & Adminstrative & Depr. & Amort Expenses | 937 | 872 | 945 | 1,021 | 1,386 |
Income After Depreciation & Amortization | 77 | 154 | 72 | 32 | -212 |
Non-Operating Income | 0 | 1 | 0 | -6 | -33 |
Interest Expense | 74 | 76 | 72 | 82 | 118 |
Pretax Income | 3 | 79 | 1 | -56 | -363 |
Income Taxes | 25 | 22 | 28 | 0 | -17 |
Minority Interest | 0 | 1 | 1 | 1 | 1 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -21 | 57 | -27 | -56 | -346 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -21 | 56 | -28 | -57 | -347 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 294 | 386 | 296 | 265 | 289 |
Depreciation & Amortization (Cash Flow) | 217 | 233 | 224 | 234 | 501 |
Income After Depreciation & Amortization | 77 | 154 | 72 | 32 | -212 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 92.40 | 92.40 | 91.80 | 91.50 | 91.00 |
Diluted EPS Before Non-Recurring Items | 1.89 | 2.04 | 2.19 | 2.25 | 2.65 |
Diluted Net EPS (GAAP) | -0.23 | 0.61 | -0.30 | -0.63 | -3.81 |
Fiscal Year end for Stericycle, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 652.00 | 653.50 | 669.50 | 684.30 |
Cost Of Goods | NA | 395.20 | 407.80 | 418.40 | 423.30 |
Gross Profit | NA | 256.80 | 245.70 | 251.10 | 261.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 219.70 | 221.50 | 275.10 | 221.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 37.10 | 24.20 | -24.00 | 40.00 |
Non-Operating Income | NA | 0.20 | 0.10 | -0.60 | 0.20 |
Interest Expense | NA | 17.00 | 17.40 | 19.10 | 20.40 |
Pretax Income | NA | 20.30 | 6.90 | -43.70 | 19.80 |
Income Taxes | NA | 5.50 | 4.80 | 5.80 | 8.50 |
Minority Interest | NA | -0.10 | 0.10 | 0.00 | 0.10 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 14.80 | 2.10 | -49.50 | 11.30 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 14.90 | 2.00 | -49.50 | 11.20 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 92.80 | 92.90 | 92.50 | 92.70 |
Diluted EPS Before Non-Recurring Items | NA | 0.54 | 0.43 | 0.43 | 0.49 |
Diluted Net EPS (GAAP) | NA | 0.17 | 0.02 | -0.54 | 0.12 |